Arene Life Sciences (Unit 4) Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 29-10-2024
- Paid Up Capital ₹ 0.10 M
as on 29-10-2024
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Ebitda
- Net Worth
- Total Assets 0.20%
(FY 2023)
About Arene Life Sciences (Unit 4)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Satyanarayana Khairtabad and Satyanarayana Chinnamail serve as directors at the Company.
- CIN/LLPIN
U24290TG2021PTC151189
- Company No.
151189
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 May 2021
- Date of AGM
20 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Arene Life Sciences (Unit 4)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satyanarayana Khairtabad  | Director | 05-May-2021 | Current |
| Satyanarayana Chinnamail | Director | 05-May-2021 | Current |
Financial Performance and Corporate Structure Insights of Arene Life Sciences (Unit 4).
Arene Life Sciences (Unit 4) Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Arene Life Sciences (Unit 4)?
Unlock access to Arene Life Sciences (Unit 4)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
S.R. Drugs And Intermediates Pvt.Ltd.Active 32 years 2 monthsSatyanarayana Khairtabad and Satyanarayana Chinnamail are mutual person
- S.R. Drugs And Intermediates (Unit 3) Private LimitedActive 4 years 6 months
Satyanarayana Khairtabad and Satyanarayana Chinnamail are mutual person
- Arene Life Sciences (Unit 3) Private LimitedActive 18 years 10 months
Satyanarayana Khairtabad and Satyanarayana Chinnamail are mutual person
- S.R. Drugs And Intermediates (Unit 2) Private LimitedActive 4 years 6 months
Satyanarayana Khairtabad and Satyanarayana Chinnamail are mutual person
Arene Life Sciences Private LimitedActive 20 years 3 monthsSatyanarayana Khairtabad and Satyanarayana Chinnamail are mutual person
Srduo Infra LlpActive 4 years 9 monthsSatyanarayana Khairtabad and Satyanarayana Chinnamail are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Arene Life Sciences (Unit 4)?
Arene Life Sciences (Unit 4) has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arene Life Sciences (Unit 4), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arene Life Sciences (Unit 4)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
